BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 195014)

  • 1. Regional, cellular and subcellular distribution of calcium-activated cyclic nucleotide phosphodiesterase and calcium-dependent regulator in porcine brain.
    Egrie JC; Campbell JA; Flangas AL; Siegel FL
    J Neurochem; 1977 Jun; 28(6):1207-13. PubMed ID: 195013
    [No Abstract]   [Full Text] [Related]  

  • 2. Adrenal medullary cyclic nucleotide phosphodiesterase: lack of activation by the calcium-dependent regulator.
    Egrie JC; Siegel FL
    Biochem Biophys Res Commun; 1975 Nov; 67(2):662-9. PubMed ID: 173325
    [No Abstract]   [Full Text] [Related]  

  • 3. Purification of calcium-dependent phosphodiesterases from rat cerebrum by affinity chromatography on activator protein-sepharose.
    Miyake M; Daly JW; Creveling CR
    Arch Biochem Biophys; 1977 May; 181(1):39-45. PubMed ID: 195535
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of cyclic nucleotide phosphodiesterases of cerebral cortex by Ca2+ and cyclic GMP.
    Filburn CR; Colpo F; Sacktor B
    J Neurochem; 1978 Feb; 30(2):337-46. PubMed ID: 203661
    [No Abstract]   [Full Text] [Related]  

  • 5. Calcium-binding proteins in electroplax and skeletal muscle. Comparison of the parvalbumin and phosphodiesterase activator protein of Electrophorus electricus.
    Childers SR; Siegel FL
    Biochim Biophys Acta; 1976 Aug; 439(2):316-25. PubMed ID: 182239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic nucleotide metabolism in electroplax of Electrophorus electricus.
    Childers SR; Siegel FL
    J Neurochem; 1977 Jun; 28(6):1229-35. PubMed ID: 195014
    [No Abstract]   [Full Text] [Related]  

  • 7. [Brain phosphodiesterase and its activator protein (author's transl)].
    Kakiuchi S
    Tanpakushitsu Kakusan Koso; 1977; 22(6):625-31. PubMed ID: 200977
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclic GMP.
    Goldberg ND; O'Dea RF; Haddox MK
    Adv Cyclic Nucleotide Res; 1973; 3():155-223. PubMed ID: 4150323
    [No Abstract]   [Full Text] [Related]  

  • 9. Possibilities for drug development based on the cyclic AMP system.
    Amer MS; McKinney GR
    Life Sci; 1973 Oct; 13(7):753-67. PubMed ID: 4358272
    [No Abstract]   [Full Text] [Related]  

  • 10. A mechanism in the control of intracellular cAMP level: the activation of a calmodulin-sensitive phosphodiesterase by a rise of intracellular free calcium.
    Erneux C; Van Sande J; Miot F; Cochaux P; Decoster C; Dumont JE
    Mol Cell Endocrinol; 1985 Dec; 43(2-3):123-34. PubMed ID: 3000848
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclic nucleotide phosphodiesterase 5 and sildenafil: promises realized.
    Manganiello V
    Mol Pharmacol; 2003 Jun; 63(6):1209-11. PubMed ID: 12761329
    [No Abstract]   [Full Text] [Related]  

  • 12. PDE inhibition and cognition enhancement.
    Blokland A; Menniti FS; Prickaerts J
    Expert Opin Ther Pat; 2012 Apr; 22(4):349-54. PubMed ID: 22475506
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.